Indication
Gastroesophageal Junction Carcinoma
6 clinical trials
15 products
Product
SGN-STNVClinical trial
A Phase 1 Study of SGN-STNV in Advanced Solid TumorsStatus: Terminated, Estimated PCD: 2024-03-01
Product
SGN-ALPVClinical trial
A Phase 1 Study of SGN-ALPV in Advanced Solid TumorsStatus: Terminated, Estimated PCD: 2023-12-13
Clinical trial
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects With Advanced MalignanciesStatus: Terminated, Estimated PCD: 2023-12-01
Product
SEA-TGTProduct
sasanlimabProduct
Brentuximab vedotinProduct
Brentuximab VedotinClinical trial
A Randomized, Double-blind, Placebo-controlled Phase 3 Trial of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy (KEYNOTE 975)Status: Active (not recruiting), Estimated PCD: 2027-02-01
Product
levoleucovorinProduct
oxaliplatinProduct
pembrolizumabProduct
placeboProduct
cisplatinProduct
5-FUProduct
leucovorinClinical trial
A Phase 1 Study of TJ033721 in Subjects With Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2024-09-01
Product
TJ033721Clinical trial
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal CancerStatus: Not yet recruiting, Estimated PCD: 2029-04-30
Product
Itraconazole